Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma.
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.